Abstract
Summary
Chemiluminescence is the process of converting chemical energy into visible light, which is the result of chemical (oxidation or hydrolysis) reactions.Chemiluminescence imaging integrated with high sensitivity, high flux and other characteristics, can detect polychromatic fluorescence, phosphor screen and chemiluminescence.It is widely used in chemiluminescence immunoassay, DNA hybridization, western blotting, southern blotting, hormones (insulin, thyroxine and estradiol), vitamins (vitamin 12), forensic medicine, tumor markers, etc.
The global market for Chemiluminescence Imaging was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Chemiluminescence Imaging was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chemiluminescence Imaging was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Chemiluminescence Imaging was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Chemiluminescence Imaging include LI-COR Biosciences, Analytik Jena, Azure Biosystems, Berthold Technologies, Bio-Rad Laboratories, Cleaver Scientific, Next Advance, Syngene (SDI Group) and GE Healthcare, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chemiluminescence Imaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Chemiluminescence Imaging by region & country, by Type, and by Application.
The Chemiluminescence Imaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemiluminescence Imaging.
Market Segmentation
By Company
LI-COR Biosciences
Analytik Jena
Azure Biosystems
Berthold Technologies
Bio-Rad Laboratories
Cleaver Scientific
Next Advance
Syngene (SDI Group)
GE Healthcare
Vilber Smart Imaging
Thermo Fisher Scientific
PerkinElmer
ANALIS
DiaSorin
Pop-Bio
UVITEC
Segment by Type:
Chemical for Chemiluminescence
Biochemical for Bioluminescence
Electromagnetic as Electroluminescence
Photons as Photoluminescence
Segment by Application
Proteomics
Genomics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Chemiluminescence Imaging manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Chemiluminescence Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Chemiluminescence Imaging in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Chemiluminescence Imaging was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Chemiluminescence Imaging was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chemiluminescence Imaging was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Chemiluminescence Imaging was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Chemiluminescence Imaging include LI-COR Biosciences, Analytik Jena, Azure Biosystems, Berthold Technologies, Bio-Rad Laboratories, Cleaver Scientific, Next Advance, Syngene (SDI Group) and GE Healthcare, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chemiluminescence Imaging, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Chemiluminescence Imaging by region & country, by Type, and by Application.
The Chemiluminescence Imaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemiluminescence Imaging.
Market Segmentation
By Company
LI-COR Biosciences
Analytik Jena
Azure Biosystems
Berthold Technologies
Bio-Rad Laboratories
Cleaver Scientific
Next Advance
Syngene (SDI Group)
GE Healthcare
Vilber Smart Imaging
Thermo Fisher Scientific
PerkinElmer
ANALIS
DiaSorin
Pop-Bio
UVITEC
Segment by Type:
Chemical for Chemiluminescence
Biochemical for Bioluminescence
Electromagnetic as Electroluminescence
Photons as Photoluminescence
Segment by Application
Proteomics
Genomics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Chemiluminescence Imaging manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Chemiluminescence Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Chemiluminescence Imaging in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Chemiluminescence Imaging Product Introduction
1.2 Global Chemiluminescence Imaging Market Size Forecast
1.3 Chemiluminescence Imaging Market Trends & Drivers
1.3.1 Chemiluminescence Imaging Industry Trends
1.3.2 Chemiluminescence Imaging Market Drivers & Opportunity
1.3.3 Chemiluminescence Imaging Market Challenges
1.3.4 Chemiluminescence Imaging Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Chemiluminescence Imaging Players Revenue Ranking (2023)
2.2 Global Chemiluminescence Imaging Revenue by Company (2019-2024)
2.3 Key Companies Chemiluminescence Imaging Manufacturing Base Distribution and Headquarters
2.4 Key Companies Chemiluminescence Imaging Product Offered
2.5 Key Companies Time to Begin Mass Production of Chemiluminescence Imaging
2.6 Chemiluminescence Imaging Market Competitive Analysis
2.6.1 Chemiluminescence Imaging Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Chemiluminescence Imaging Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemiluminescence Imaging as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemical for Chemiluminescence
3.1.2 Biochemical for Bioluminescence
3.1.3 Electromagnetic as Electroluminescence
3.1.4 Photons as Photoluminescence
3.2 Global Chemiluminescence Imaging Sales Value by Type
3.2.1 Global Chemiluminescence Imaging Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Chemiluminescence Imaging Sales Value, by Type (2019-2030)
3.2.3 Global Chemiluminescence Imaging Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Proteomics
4.1.2 Genomics
4.1.3 Other
4.2 Global Chemiluminescence Imaging Sales Value by Application
4.2.1 Global Chemiluminescence Imaging Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Chemiluminescence Imaging Sales Value, by Application (2019-2030)
4.2.3 Global Chemiluminescence Imaging Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Chemiluminescence Imaging Sales Value by Region
5.1.1 Global Chemiluminescence Imaging Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Chemiluminescence Imaging Sales Value by Region (2019-2024)
5.1.3 Global Chemiluminescence Imaging Sales Value by Region (2025-2030)
5.1.4 Global Chemiluminescence Imaging Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Chemiluminescence Imaging Sales Value, 2019-2030
5.2.2 North America Chemiluminescence Imaging Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Chemiluminescence Imaging Sales Value, 2019-2030
5.3.2 Europe Chemiluminescence Imaging Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Chemiluminescence Imaging Sales Value, 2019-2030
5.4.2 Asia Pacific Chemiluminescence Imaging Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Chemiluminescence Imaging Sales Value, 2019-2030
5.5.2 South America Chemiluminescence Imaging Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Chemiluminescence Imaging Sales Value, 2019-2030
5.6.2 Middle East & Africa Chemiluminescence Imaging Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Chemiluminescence Imaging Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Chemiluminescence Imaging Sales Value
6.3 United States
6.3.1 United States Chemiluminescence Imaging Sales Value, 2019-2030
6.3.2 United States Chemiluminescence Imaging Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Chemiluminescence Imaging Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Chemiluminescence Imaging Sales Value, 2019-2030
6.4.2 Europe Chemiluminescence Imaging Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Chemiluminescence Imaging Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Chemiluminescence Imaging Sales Value, 2019-2030
6.5.2 China Chemiluminescence Imaging Sales Value by Type (%), 2023 VS 2030
6.5.3 China Chemiluminescence Imaging Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Chemiluminescence Imaging Sales Value, 2019-2030
6.6.2 Japan Chemiluminescence Imaging Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Chemiluminescence Imaging Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Chemiluminescence Imaging Sales Value, 2019-2030
6.7.2 South Korea Chemiluminescence Imaging Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Chemiluminescence Imaging Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Chemiluminescence Imaging Sales Value, 2019-2030
6.8.2 Southeast Asia Chemiluminescence Imaging Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Chemiluminescence Imaging Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Chemiluminescence Imaging Sales Value, 2019-2030
6.9.2 India Chemiluminescence Imaging Sales Value by Type (%), 2023 VS 2030
6.9.3 India Chemiluminescence Imaging Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 LI-COR Biosciences
7.1.1 LI-COR Biosciences Profile
7.1.2 LI-COR Biosciences Main Business
7.1.3 LI-COR Biosciences Chemiluminescence Imaging Products, Services and Solutions
7.1.4 LI-COR Biosciences Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.1.5 LI-COR Biosciences Recent Developments
7.2 Analytik Jena
7.2.1 Analytik Jena Profile
7.2.2 Analytik Jena Main Business
7.2.3 Analytik Jena Chemiluminescence Imaging Products, Services and Solutions
7.2.4 Analytik Jena Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.2.5 Analytik Jena Recent Developments
7.3 Azure Biosystems
7.3.1 Azure Biosystems Profile
7.3.2 Azure Biosystems Main Business
7.3.3 Azure Biosystems Chemiluminescence Imaging Products, Services and Solutions
7.3.4 Azure Biosystems Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.3.5 Berthold Technologies Recent Developments
7.4 Berthold Technologies
7.4.1 Berthold Technologies Profile
7.4.2 Berthold Technologies Main Business
7.4.3 Berthold Technologies Chemiluminescence Imaging Products, Services and Solutions
7.4.4 Berthold Technologies Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.4.5 Berthold Technologies Recent Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Profile
7.5.2 Bio-Rad Laboratories Main Business
7.5.3 Bio-Rad Laboratories Chemiluminescence Imaging Products, Services and Solutions
7.5.4 Bio-Rad Laboratories Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.5.5 Bio-Rad Laboratories Recent Developments
7.6 Cleaver Scientific
7.6.1 Cleaver Scientific Profile
7.6.2 Cleaver Scientific Main Business
7.6.3 Cleaver Scientific Chemiluminescence Imaging Products, Services and Solutions
7.6.4 Cleaver Scientific Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.6.5 Cleaver Scientific Recent Developments
7.7 Next Advance
7.7.1 Next Advance Profile
7.7.2 Next Advance Main Business
7.7.3 Next Advance Chemiluminescence Imaging Products, Services and Solutions
7.7.4 Next Advance Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.7.5 Next Advance Recent Developments
7.8 Syngene (SDI Group)
7.8.1 Syngene (SDI Group) Profile
7.8.2 Syngene (SDI Group) Main Business
7.8.3 Syngene (SDI Group) Chemiluminescence Imaging Products, Services and Solutions
7.8.4 Syngene (SDI Group) Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.8.5 Syngene (SDI Group) Recent Developments
7.9 GE Healthcare
7.9.1 GE Healthcare Profile
7.9.2 GE Healthcare Main Business
7.9.3 GE Healthcare Chemiluminescence Imaging Products, Services and Solutions
7.9.4 GE Healthcare Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.9.5 GE Healthcare Recent Developments
7.10 Vilber Smart Imaging
7.10.1 Vilber Smart Imaging Profile
7.10.2 Vilber Smart Imaging Main Business
7.10.3 Vilber Smart Imaging Chemiluminescence Imaging Products, Services and Solutions
7.10.4 Vilber Smart Imaging Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.10.5 Vilber Smart Imaging Recent Developments
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Profile
7.11.2 Thermo Fisher Scientific Main Business
7.11.3 Thermo Fisher Scientific Chemiluminescence Imaging Products, Services and Solutions
7.11.4 Thermo Fisher Scientific Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.11.5 Thermo Fisher Scientific Recent Developments
7.12 PerkinElmer
7.12.1 PerkinElmer Profile
7.12.2 PerkinElmer Main Business
7.12.3 PerkinElmer Chemiluminescence Imaging Products, Services and Solutions
7.12.4 PerkinElmer Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.12.5 PerkinElmer Recent Developments
7.13 ANALIS
7.13.1 ANALIS Profile
7.13.2 ANALIS Main Business
7.13.3 ANALIS Chemiluminescence Imaging Products, Services and Solutions
7.13.4 ANALIS Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.13.5 ANALIS Recent Developments
7.14 DiaSorin
7.14.1 DiaSorin Profile
7.14.2 DiaSorin Main Business
7.14.3 DiaSorin Chemiluminescence Imaging Products, Services and Solutions
7.14.4 DiaSorin Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.14.5 DiaSorin Recent Developments
7.15 Pop-Bio
7.15.1 Pop-Bio Profile
7.15.2 Pop-Bio Main Business
7.15.3 Pop-Bio Chemiluminescence Imaging Products, Services and Solutions
7.15.4 Pop-Bio Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.15.5 Pop-Bio Recent Developments
7.16 UVITEC
7.16.1 UVITEC Profile
7.16.2 UVITEC Main Business
7.16.3 UVITEC Chemiluminescence Imaging Products, Services and Solutions
7.16.4 UVITEC Chemiluminescence Imaging Revenue (US$ Million) & (2019-2024)
7.16.5 UVITEC Recent Developments
8 Industry Chain Analysis
8.1 Chemiluminescence Imaging Industrial Chain
8.2 Chemiluminescence Imaging Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Chemiluminescence Imaging Sales Model
8.5.2 Sales Channel
8.5.3 Chemiluminescence Imaging Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer